Form 4: Ecolab Director Acquires Stock Options
Statement of Changes in Beneficial Ownership
Ecolab Inc. director Michel D. Doukeris acquired stock options, as disclosed in a Form 4 filing.
Summary
- Michel D. Doukeris, a Director at Ecolab Inc., acquired a non-employee director stock option on May 15, 2026.
- The option grants the right to buy 732 shares of Ecolab's common stock.
- The exercise price for the option is $247.70 per share.
- The option is exercisable starting August 15, 2026, and expires on May 15, 2036.
- Vesting occurs on a cumulative basis, with 25% vesting after the first three months, and the remainder vesting by the end of the fourth three-month period or the next annual meeting, whichever comes first.
- The option becomes fully exercisable immediately in the event of a Change in Control of the Company.
- Following the transaction, Doukeris directly beneficially owns 576.26 shares of common stock.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral filing, as it reports a standard stock option grant to a director, which is a common compensation practice and does not inherently signal positive or negative performance.
Positives
- Director acquisition of stock options can signal confidence in the company's future performance.
- The option grant is structured with vesting over time, aligning with long-term company goals.
- The inclusion of an acceleration clause upon Change in Control provides potential upside for the director in a significant corporate event.
Negatives
- The filing only details the acquisition of options, not the actual purchase or sale of common stock, so immediate financial impact is not evident.
Risks
- The value of the stock option is subject to market fluctuations and the future performance of Ecolab Inc.
- If the company's stock price does not exceed the exercise price of $247.70, the options may not be profitable to exercise.
- The vesting schedule means the director cannot immediately realize the full value of the options.
Future Outlook
The filing does not contain forward-looking statements or guidance regarding future financial performance. It solely reports a transaction related to stock options.
Industry Context
StockSavvy.ai notes that the acquisition of stock options by directors is a common practice in the chemicals and water treatment industry, often used as a long-term incentive to align executive interests with shareholder value. Ecolab Inc. operates in a competitive landscape where such compensation structures are standard.
Stakeholder Impact
- Shareholders: The grant of options to directors is a standard compensation practice. The ultimate impact on shareholders depends on the company's future stock performance and the director's exercise of these options.
- Employees: This filing does not directly impact employees, but it reflects the company's compensation strategy for its board members.
- Management: The director receives a long-term incentive that aligns their interests with the company's long-term success.
Next Steps
- The stock option will begin vesting on August 15, 2026.
- The option will expire on May 15, 2036, unless exercised earlier.
- The option will become fully exercisable in the event of a Change in Control.
Key Dates
| Date | Description |
|---|---|
| 05/15/2026 | Earliest transaction date; Date of grant for stock option. |
| 08/15/2026 | First vesting date for the stock option. |
| 05/15/2036 | Expiration date of the stock option. |
| 05/19/2026 | Date the Form 4 was signed. |
Keywords
Ecolab Inc., ECL, Form 4, Stock Options, Director, Beneficial Ownership, SEC Filing, Insider Trading, Executive Compensation
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.